<DOC>
	<DOC>NCT01602081</DOC>
	<brief_summary>The LIFT+Biodesign® study is a post-market observational study to evaluate the rate of fistula closure in patients with persistent trans-sphincteric anal fistula who receive the Biodesign® Tissue graft as part of their LIFT procedure.</brief_summary>
	<brief_title>Ligation of the Intersphincteric Fistula Tract (LIFT) + Biodesign for Anal Fistula</brief_title>
	<detailed_description />
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Rectal Fistula</mesh_term>
	<criteria>Persistent primary or recurrent transsphincteric anal fistula Patients with prior fistulotomy, fistulectomy, LIFT, cutting seton or advancement flap procedure Fistula with multiple tracts Rectovaginal fistula Active infection in the anal fistula Physical allergies or cultural objections to porcine products Patient is not medically fit to undergo the LIFT procedure as judged by the treating physician Previous diagnosis of collagen disorder History of Crohn's Disease, Irritable Bowel Syndrome, radiation therapy in the rectoanal region</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Anal fistula</keyword>
	<keyword>Ligation of the intersphincteric fistula tract</keyword>
	<keyword>LIFT</keyword>
	<keyword>Tissue graft</keyword>
</DOC>